Maria I. Kontaridis, Ph.D.
Affiliations: | 2002 | Yale University, New Haven, CT |
Area:
Pharmacology, Molecular Biology, Cell BiologyGoogle:
"Maria Kontaridis"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Anton M. Bennett | grad student | 2002 | Yale | |
| (Function of the SH2 domain-containing protein tyrosine phosphatase, SHP -2, in myogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pierpont EI, Bennett AM, Schoyer L, et al. (2023) The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy. American Journal of Medical Genetics. Part A |
| Kontaridis MI, Chennappan S. (2022) Mitochondria and the future of RASopathies: the emergence of bioenergetics. The Journal of Clinical Investigation. 132: 1-5 |
| Kontaridis MI, Roberts AE, Schill L, et al. (2022) The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery. American Journal of Medical Genetics. Part A |
| Gripp KW, Schill L, Schoyer L, et al. (2019) The sixth international RASopathies symposium: Precision medicine-From promise to practice. American Journal of Medical Genetics. Part A |
| Jaffré F, Miller CL, Schänzer A, et al. (2019) iPSC-Derived Cardiomyocytes Reveal Aberrant ERK5 and MEK1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome. Circulation |
| Kaikkonen LA, Sätzler V, Roy A, et al. (2019) Abstract 252: Activated Fibroblast-specific Deletion of RhoA Reduces Cardiac Fibrosis Through Regulation of the Non-canonical p38-MAPK Signaling Pathway Circulation Research. 125 |
| Li R, Baskfield A, Lin Y, et al. (2018) Generation of an induced pluripotent stem cell line (TRNDi003-A) from a Noonan syndrome with multiple lentigines (NSML) patient carrying a p.Q510P mutation in the PTPN11 gene. Stem Cell Research. 34: 101374 |
| Zheng H, Yu WM, Waclaw RR, et al. (2018) Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner. Science Signaling. 11 |
| Sun C, Kontaridis MI. (2018) Physiology of Cardiac Development: From Genetics to Signaling to Therapeutic Strategies. Current Opinion in Physiology. 1: 123-139 |
| Wang J, Chandrasekhar V, Abbadessa G, et al. (2017) In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy. Plos One. 12: e0178905 |